Automatic Website Traffic RSS

Velcade(R) Plus Doxil(R) Improves Previously Treated Multiple Myeloma Patients

NORTH HOLLYWOOD, Calif., and CHICAGO, The International Myeloma Foundation (IMF)-supporting research and providing education, advocacy and support for myeloma patients, families, researchers and ... read more

Harnessing the Potential of Lipid-based Nanomedicines for Type-specific Ovarian Cancer Treatments

Pegylated liposomal doxorubicin (Doxil ®) is the only approved, routinely used nanocarrier formulation for EOC. It may be considered a viable first-line alternative to paclitaxel in standard ... read more

Nanoparticle therapeutics: an emerging treatment modality for cancer

For example, although Doxil has been shown to have reduced cardiotoxicity compared with free doxorubicin, it also has skin toxicity that is not observed with the drug alone 22. Newer nanoparticle ... read more

Combining Nanomedicines and Metronomic Scheduling May Help Improve Cancer Treatment Strategies

Furthermore, in mice with triple negative breast cancer or fibrosarcoma, Doxil — a nanomedicine that is approved to treat metastatic breast cancer and comprises of doxorubicin encapsulated in a lipid ... read more

Advancing Patient Care: The Role of Polymer-Based Drug Delivery in Cancer Treatment

By Taha KhanApr 4 2024Reviewed by Lexie Corner Materials science plays a vital role in cancer care, particularly through the development of innovative polymer-based drug delivery systems. These ... read more

Complement monitoring of carbon nanotubes

Doxil) 7. Clinical experience based on liposome therapeutics indicates that PEGylated lipids can induce complement activation in up to 10% of treated patients 8. Our Progress Article did not ... read more

Drug delivery liposomes and extracellular vesicles

J. Phys. Chem. C 118(33), pp. 19444-19449 (2014). Aniket Magarkar, Tomasz Róg and Alex Bunker: Molecular dynamics simulation of PEGylated membranes with cholesterol: building toward the DOXIL ... read more